Skip to content
Trial Eligibility
Menu

Intestinal Immunity in Neurologic Disease

NCT06329453

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to ascertain the functional profiles of the immune cells within the gastrointestinal tract and to determine how these cells contribute to autoimmune and neurologic diseases.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Multiple Sclerosis
  • Parkinson Disease
  • REM Sleep Behavior Disorder

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 99 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Yale University
Last updated on ClinicalTrials.gov
May 27, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Connecticut · 1

  • Yale MS Clinic · North Haven, CT

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.